Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Huadong Medicine Co. Ltd. recently revealed data from in vitro and preclinical studies performed to evaluate the efficacy and pharmacokinetic, safety and tolerability profiles of a dual glucagon-like ...

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Two new therapies have successfully cleared tau aggregates in preclinical and mouse models, showing potential as dementia ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given researchers a deeper insight into how prostate cancer spreads or metastasizes.

Rakuten Medical Inc. has presented preclinical results with RM-0256, a PD-L1-targeted photoimmunotherapy, showing its ability ...

Late-breaking oral presentation will discuss the potential of ZL-1503 as a novel treatment for moderate-to-severe atopic ...

The option gives Glaukos exclusive global license agreements on pre-agreed terms, including upfront and milestone payments ...

The field of small animal imaging has seen significant advancements, driven by the increasing demand for precise, ...

A biomarker of eight microRNAs forms a "fingerprint" of ALS in the blood, which can be detected with 98% accuracy in a ...

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease Prescreening rate of Phase 2b ReTain trial triggers clinical ...